FTC clears Roche acquisition of Marcadia

The Federal Trade Commission granted early termination to the waiting period under the Hart-Scott-Rodino Act for a proposed acquisition of diabetes and obesity company Marcadia Biotech Inc. (Carmel, Ind.) by Roche (SIX:ROG; OTCQX:RHHBY). Further details were not disclosed. Neither company could be reached for comment. Under Hart-Scott-Rodino, companies are required to file premerger notification and wait for government review of a potential large merger or acquisition. If the waiting period expires or is terminated, the companies are free to close their deal. ...